Soterix Medical's portable SPRY TMS system cleared for depression
The FDA clearance covers adults with major depression who haven't responded to medication; the system emphasizes portability and continuous operation.
Soterix Medical has received FDA clearance for its SPRY transcranial magnetic stimulation system for adults with major depressive disorder who haven’t responded adequately to antidepressants. The company highlights SPRY’s portability, liquid cooling for back-to-back sessions, a touchscreen interface, interchangeable coils and optional neuronavigation.
More compact, easier-to-run TMS systems could help the therapy spread beyond specialist clinics.
Learn more: TMS · Soterix Medical